TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease-Reference-Cited by-同舟云学术

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease

Published:2019-07-31 Issue:7 Volume:13 Page:e0007602
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Ferreira Roberto Rodrigues,Abreu Rayane da Silva,Vilar-Pereira Glaucia,Degrave Wim,Meuser-Batista Marcelo,Ferreira Nilma Valéria Caldeira,da Cruz Moreira Otacílio,da Silva Gomes Natália Lins,Mello de Souza Elen,Ramos Isalira P.,Bailly Sabine,Feige Jean-Jacques,Lannes-Vieira Joseli^ORCID,de Araújo-Jorge Tania C.,Waghabi Mariana Caldas^ORCID

Funder

FAPERJ

CNPq

Fundação Oswaldo Cruz

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference60 articles.

1. Lessons for cardiac regeneration and repair through development;J Alexander;Trends Mol Med,2010

2. Chagas heart disease: Pathophysiologic mechanisms, prognostic factors and risk stratification;A Rassi;Mem Inst Oswaldo Cruz,2009

3. Transforming growth factor (TGF)-β signaling in cardiac remodeling;M Dobaczewski;J Mol Cell Cardiol,2011